Results of this analyses showed that both serum and PBCs mRNA levels of Klotho were covariates associated with subclinical atherosclerosis, indicating that the levels of both variables are protective factors for the presence of this condition in CKD patients in stage 3–4 (Table 4 and Fig. 1). Here, KL is linked to chronic kidney disease.